Overview

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

Status:
Not yet recruiting
Trial end date:
2027-03-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy of an implantable etonogestrel device in reducing hysterectomy rate in patients with a failed endometrial ablation.
Phase:
Phase 2
Details
Lead Sponsor:
Saskatchewan Health Authority - Regina Area
Collaborator:
University of Saskatchewan
Treatments:
Desogestrel
Etonogestrel